Ask AI

Interactive Case Challenge

Share

Program Content

Activities

  • EGFRm NSCLC Progression on Osimertinib
    Management of a Patient With EGFR-Mutated NSCLC and Progression on First-line Osimertinib
    Case Challenge
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 17, 2026

    Expires: October 16, 2026

Provided by

ProCE Banner

rovided by Clinical Care Options, LLC dba Decera Clinical Education

Supporters

Supported by educational grants from AstraZeneca and Daiichi Sankyo, Inc.

AstraZeneca

Daiichi Sankyo, Inc.